The Middle EAST Gene Transfer Technologies Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several key factors, including increasing investments in biotechnology, rising prevalence of genetic disorders, and advancements in gene editing technologies. The region is witnessing a...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek